Disclosure context

About spacebears

Spacebears is a recently emerged ransomware group first observed in April 2024, operating with apparent financial motivations and demonstrating a broad targeting approach across multiple sectors and geographic regions. The group's origin and potential affiliations remain unclear due to limited public documentation from established threat intelligence sources, though their targeting pattern suggests a professional operation focused on maximizing financial returns rather than geopolitical objectives. With 117 known victims since their emergence, Spacebears has shown particular focus on organizations in the United States, Germany, Spain, Italy, and Canada, with their attacks primarily affecting technology, healthcare, manufacturing, and business services sectors, indicating they likely employ opportunistic targeting rather than sector-specific specialization. Their attack methodology, initial access vectors, and specific technical capabilities have not been extensively documented in public reporting from major cybersecurity firms or law enforcement agencies, limiting detailed analysis of their operational procedures and tools. Due to the group's recent emergence and limited public intelligence reporting, notable high-profile campaigns and specific victim details remain largely undocumented in established threat intelligence channels. The group's current operational status appears active given their recent emergence timeline, though comprehensive analysis is constrained by the lack of detailed public reporting from authoritative cybersecurity sources. The group has been linked to 147 public disclosures across our corpus. First observed on a leak site on April 29, 2024; most recent post May 13, 2026. The operation is currently active.

Also tracked as: space bears.

Timeline of this disclosure

May 4, 2026Johnson & Johnson Innovative Medicine listed by spacebearson the group's public leak site

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 1,779 disclosures indexed across all operators we track. Geographically, Johnson & Johnson Innovative Medicine is reported in US, a country with 2,713 ransomware disclosures in our corpus.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.

Ransomware victim disclosure

← All victims

Johnson & Johnson Innovative Medicine

Claimed by spacebears · listed 17 days ago

16d

Age

since listed · data leaked

Status timeline

Listed
May 4, 2026
Data leaked

At a glance

Group: spacebears
Status: Data leaked
Country: US
Sector: Healthcare
Listed on leak site: May 4, 2026

About the victim

AI dossier — public-source company profile

Johnson & Johnson Innovative Medicine, formerly known as Janssen Pharmaceuticals, is the pharmaceutical division of Johnson & Johnson, headquartered in New Brunswick, New Jersey. The division specializes in the research, development, and commercialization of prescription medicines across therapeutic areas including oncology, immunology, neuroscience, and infectious disease. It operates globally and is one of the largest pharmaceutical enterprises in the world.

Industry: Pharmaceutical Research & Development
Address: One Johnson & Johnson Plaza, New Brunswick, NJ 08933, USA
Employees: 10000+
Founded: 1886

Attack summary

Severity: critical — The victim is a major pharmaceutical division of a Fortune 500 healthcare corporation. The disclosed status is 'data_published', indicating confirmed exfiltration of data that is highly likely to include regulated information such as clinical trial data, patient-related records, proprietary drug research, and sensitive business data at significant scale.

The spacebears ransomware group claims to have attacked Johnson & Johnson Innovative Medicine and has published data, indicating confirmed exfiltration; however, no specific data size or ransom demand was stated in the post.

critical

Data the group says was taken

AI dossier — extracted from the leak post

Pharmaceutical research data
Corporate business data
Potentially proprietary drug development records

What the group claims

Johnson & Johnson Innovative Medicine (formerly known as Janssen Pharmaceuticals) is the pharmaceutical division of the American corporation Johnson & Johnson, specializing in the development and production of revolutionary medicines. The company focuses on creating treatments for the most complex diseases, transforming the future of healthcare.-CAR-T Research https://www.jnj.com/innovativemedicine/

The leak post

captured from the group's site

## Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine (formerly known as Janssen Pharmaceuticals) is the pharmaceutical division of the American corporation Johnson & Johnson, specializing in the development and production of revolutionary medicines. The company focuses on creating treatments for the most complex diseases, transforming the future of healthcare.

Screenshot of the leak post

Leak screenshot for Johnson & Johnson Innovative Medicine

Sources

Source

Indexed 17 days ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.